SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,600,551 | +10.6% | 888,995 | +0.3% | 0.07% | +20.0% |
| Q2 2023 | $170,596,389 | +4.1% | 886,400 | +9.6% | 0.06% | -6.8% |
| Q1 2023 | $163,812,805 | +60.6% | 809,072 | +1.9% | 0.06% | +51.3% |
| Q4 2022 | $102,031,676 | -8.6% | 793,959 | -2.7% | 0.04% | -11.4% |
| Q3 2022 | $111,601,000 | -24.6% | 815,615 | -2.5% | 0.04% | -15.4% |
| Q2 2022 | $147,976,000 | +18.3% | 836,304 | -3.7% | 0.05% | +36.8% |
| Q1 2022 | $125,108,000 | -0.3% | 868,505 | +7.0% | 0.04% | 0.0% |
| Q4 2021 | $125,546,000 | -12.2% | 812,066 | -3.6% | 0.04% | -17.4% |
| Q3 2021 | $143,022,000 | +7.7% | 842,292 | +0.1% | 0.05% | +4.5% |
| Q2 2021 | $132,851,000 | +29.5% | 841,472 | +13.9% | 0.04% | +15.8% |
| Q1 2021 | $102,555,000 | -20.1% | 738,555 | +0.8% | 0.04% | -24.0% |
| Q4 2020 | $128,303,000 | – | 732,575 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |